Breaking News Instant updates and real-time market news.

PPG

PPG

$109.63

-2.97 (-2.64%)

, SHW

Sherwin-Williams

$424.93

-8.77 (-2.02%)

10:03
03/22/19
03/22
10:03
03/22/19
10:03

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PPG (PPG) downgraded to Underweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying PPG shares have been drifting higher in 2019 as the market continues to prefer higher quality and less cyclical materials companies, however general economic business conditions are "arguably weaker than they have been because of decreased rates of economic growth in China and in Europe." 2. Sherwin-Williams (SHW) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 3. Booking Holdings (BKNG) downgraded to Neutral from Outperform at Wedbush with analyst James Hardiman stating that he believes the company's dominant position in Europe will be favorable in the long term, but is likely to represent a liability in 2019 as it is could amplify risks of earnings revisions and multiple compression. 4. Biogen (BIIB) downgraded to Underweight from Overweight at Morgan Stanley with analyst Matthew Harrison citing the failure of two Alzheimer's disease trials and noting that his optimism on Alzheimer's was "completely wrong." 5. Lululemon (LULU) downgraded to Neutral from Outperform at Wedbush with analyst Jen Redding saying that while she continues to see lululemon as best in class among specialty retailers, she is moving to the sidelines in anticipation of potentially less margin upside ahead, based on insights from proprietary data products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PPG

PPG

$109.63

-2.97 (-2.64%)

SHW

Sherwin-Williams

$424.93

-8.77 (-2.02%)

BKNG

Booking Holdings

$1,743.00

-29.07 (-1.64%)

BIIB

Biogen

$223.72

-2.99 (-1.32%)

LULU

Lululemon

$146.73

-2.22 (-1.49%)

  • 25

    Mar

  • 27

    Mar

  • 17

    Apr

  • 18

    Apr

  • 24

    Apr

  • 30

    Apr

  • 01

    May

PPG PPG
$109.63

-2.97 (-2.64%)

01/18/19
FBCO
01/18/19
NO CHANGE
Target $112
FBCO
Neutral
PPG price target cut to $112 from $115 at Credit Suisse
Credit Suisse analyst Christopher Parkinson maintained a Neutral rating on PPG and cut his price target to $112 following the company's quarterly earnings report on Thursday. In a research note to investors, Parkinson said that while it is "encouraging" that PPG's pricing is beginning to outpace cost inflation, y/y margin recovery is still several quarters away. The analyst says he sees the potential for a positive set-up in 2H and views the story as relatively "de-risked" given lower guidance, he remains on the sidelines as PPG is far from "out of the woods."
03/22/19
JPMS
03/22/19
DOWNGRADE
Target $106
JPMS
Underweight
JPMorgan downgrades PPG to Underweight, says company split unlikely
JPMorgan analyst Jeffrey Zekauskas downgraded PPG Industries to Underweight from Neutral with an unchanged price target of $106. PPG shares have been drifting higher in 2019 as the market continues to prefer higher quality and less cyclical materials companies to their more cyclical counterparts, Zekauskas tells investors in a research note. However, the analyst believes general economic business conditions are "arguably weaker than they have been because of decreased rates of economic growth in China and in Europe." He continues to think that an 11.5 times multiple of 2019 EBITDA represents fair value for PPG, which implies a $106 share price objective for 2019. Further, PPG is unlikely to split itself into two different coatings entities as Trian has suggested, Zekauskas contends.
03/22/19
JPMS
03/22/19
DOWNGRADE
Target $106
JPMS
Underweight
PPG downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded PPG Industries to Underweight from Neutral with an unchanged price target of $106.
01/22/19
RHCO
01/22/19
NO CHANGE
Target $110
RHCO
Hold
PPG price target raised to $110 from $105 at SunTrust
SunTrust analyst James Sheehan raised his price target on PPG to $110 after its Q4 results, saying the stock price was driven higher by investors looking beyond the "subdued" 2019 outlook and favoring the company's considered split in response to shareholder impact. The analyst adds that the 2.5-turn discount valuation on PPG could be narrowed in the event of a break-up over time. In the near term, Sheehan cites the rising FX and cost inflation, along with the continued headwinds in auto production, pressuring the company's first-half earnings, and keephis Hold rating on PPG shares.
SHW Sherwin-Williams
$424.93

-8.77 (-2.02%)

03/22/19
JPMS
03/22/19
DOWNGRADE
Target $435
JPMS
Neutral
Sherwin-Williams downgraded to Neutral on valuation at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Sherwin-Williams to Neutral from Overweight with an unchanged price target of $435. With the stock near this target, the analyst downgrades the company on valuation. Sherwin is a high-quality company that trades at multiples that are among the highest in the coatings universe, Zekauskas tells investors in a research note.
03/15/19
DBAB
03/15/19
NO CHANGE
DBAB
Buy
Sherwin-Williams investor doubt creates share opportunity, says Deutsche Bank
After hosting investor meetings with management, Deutsche Bank analyst Nishu Sood says that that barring macro turmoil, Sherwin-Williams' 2019 should look much better than 2018 did. With so many factors dragging on Sherwin's results in fiscal 2018, the end result is that doubt has crept into investors' minds about the company's longer-term ability to drive earnings growth, Sood tells investors in a research note. He disagrees, and thinks this doubt creates opportunity in Sherwin's stock. "Not only do we see Sherwin's ability to drive growth longer-term as intact, but also, we think this growth potential is compelling and multi-faceted," says the analyst. Sherwin-Williams remains one of his picks in the building products space.
03/22/19
JPMS
03/22/19
DOWNGRADE
Target $435
JPMS
Neutral
Sherwin-Williams downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Sherwin-Williams to Neutral from Overweight with an unchanged price target of $435.
03/20/19
EVER
03/20/19
INITIATION
Target $495
EVER
Outperform
Sherwin-Williams initiated with an Outperform at Evercore ISI
Evercore ISI analyst Greg Melich started Sherwin-Williams with an Outperform rating and $495 base case price target, calling its controlled distribution, loyal contractor base, pricing power, and Valspar merger synergies "positives that shouldn't be overlooked."
BKNG Booking Holdings
$1,743.00

-29.07 (-1.64%)

03/19/19
TLSY
03/19/19
DOWNGRADE
TLSY
Market Perform
Booking Holdings downgraded to Market Perform from Outperform at Telsey Advisory
02/28/19
02/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Booking Holdings (BKNG) downgraded to Neutral from Overweight at Atlantic Equities and Piper Jaffray, as well as to Perform from Outperform at Oppenheimer. 2. Box (BOX) downgraded to Sector Weight from Overweight at KeyBanc and to Neutral from Buy at Rosenblatt. 3. HP Inc. (HPQ) double downgraded to Underperform from Buy at BofA/Merrill with analyst Wamsi Mohan citing the company's Q1 report last night. 4. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank. 5. Dollar General (DG) and Big Lots (BIG) were downgraded to Hold from Buy at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/22/19
WEDB
03/22/19
DOWNGRADE
WEDB
Neutral
Booking Holdings downgraded to Neutral from Outperform at Wedbush
03/22/19
WEDB
03/22/19
DOWNGRADE
Target $1850
WEDB
Neutral
Wedbush downgrades Booking Holdings to Neutral on European exposure
As previously reported, Wedbush analyst James Hardiman downgraded Booking Holdings to Neutral from Outperform, stating that he believes the company's dominant position in Europe will be favorable in the long term, but is likely to represent a liability in 2019 as it is could amplify risks of earnings revisions and multiple compression. His recent survey of nearly 200 consumers from the U.K. and Europe showed that Brexit-related uncertainty is significant and appears to be worsening, said Hardiman, who also noted near and medium-term issues in continental Europe. He lowered his price target on Booking shares to $1,850 from $2,000.
BIIB Biogen
$223.72

-2.99 (-1.32%)

03/22/19
MSCO
03/22/19
DOWNGRADE
Target $210
MSCO
Underweight
Morgan Stanley double downgrades Biogen to Underweight after Alzheimer's failure
As previously reported, Morgan Stanley analyst Matthew Harrison downgraded Biogen to Underweight from Overweight after the company announced the failure of two Alzheimer's disease trials, noting that his optimism on Alzheimer's was "completely wrong." Without that potential upside driver, Harrison does not expect a near-term recovery in Biogen shares, though he admits that a significant acquisition that accelerates topline growth "represents the major risk" to his Underweight thesis. Absent M&A, he sees no near-to-midterm upside driver and believes downside risks from Spinraza competition and challenges to Tecfidera's patents are exposed. Harrison lowered his price target on Biogen shares to $210 from $401.
03/22/19
BMOC
03/22/19
NO CHANGE
Target $250
BMOC
Market Perform
Biogen price target lowered to $250 from $322 at BMO Capital
BMO Capital analyst George Farmer lowered his price target on Biogen to $250 and kept his Market Perform rating after the phase 3 trial failure of aducanumab. The analyst believes that investor sentiment on the stock will remain negative for some time, while the current valuation will keep potential acquirers from considering a bid. Farmer adds that he is looking ahead to the results of Biogen's Phase 2 trial of BIIB092 in progressive supranuclear palsy expected to be announced in Q4 of this year.
03/22/19
UBSW
03/22/19
DOWNGRADE
Target $242
UBSW
Neutral
UBS downgrades Biogen to Neutral, cuts target to $242 from $395
UBS analyst Carter Gould downgraded Biogen to Neutral from Buy and lowered his price target for the shares to $242 from $395. The failure of aducanumab leaves Biogen with a lack of visibility around a path back to sales growth, Gould tells investors in a research note. As a result, the threats to Tecfidera intellectual property beyond 2020 and competition to Spinraza "should dominate the narrative over the near-term," says the analyst.
03/22/19
JEFF
03/22/19
NO CHANGE
Target $250
JEFF
Hold
Biogen shares still not trading at 'Uber-Bear case' yet, says Jefferies
Jefferies analyst Michael Yee lowered his price target for Biogen to $250 from $380 and maintains a Hold rating on the shares following yesterday's Alzheimer's failure. The stock, while "cheap," is not trading at an "Uber-Bear case" yet, Yee tells investors in a research note. The analyst sees downside risk to $175-$200 per share amid the "binary overhang and uncertainty" from the Tecfidera inter partes review. Further, Yee believes Spinraza consensus estimates still have to come down. He maintains a Hold rating on Biogen.
LULU Lululemon
$146.73

-2.22 (-1.49%)

03/21/19
COWN
03/21/19
NO CHANGE
Target $190
COWN
Outperform
Cowen sees map to $25B+ valuation of Lululemon ahead of April investor day
Cowen analyst John Kernan maintained an Outperform rating on Lululemon and raised his price target to $190 from $188 ahead of the company's investor day event on April 24. In a research note to investors, Kernan says checks and comScore data suggest no moderation from Q4 trends and he sees a financial roadmap to $25B+ valuation over time.
03/20/19
LEHM
03/20/19
NO CHANGE
Target $200
LEHM
Overweight
Barclays remains 'aggressive buyers' of the Lululemon story
Barclays analyst Matthew McClintock says his firm remains "aggressive buyers" of the Lululemon story. The company has a significantly larger total addressable market than even the most optimistic estimates likely expect, McClintock tells investors in a research note titled " 4Q18: Unrestricted Growth." Furthermore, the analyst points out that Nike (NKE) even addressed that apparel is an "extraordinary opportunity" for growth as athletic apparel's penetration rate in the overall apparel market is low and customers are increasingly choosing performance and sportswear for more occasions. A potential catalyst to understanding the longer-term potential for Lululemon will likely come with its investor day on April 24, says McClintock. He increased his Q4 earnings per share estimate to $1.74 from $1.64 and keeps an Overweight rating on Lululemon with a $200 price target.
03/22/19
WEDB
03/22/19
DOWNGRADE
Target $155
WEDB
Neutral
Lululemon downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Jen Redding downgraded lululemon to Neutral from Outperform and lowered her price target to $155 from $176. In a research note to investors, Redding says that while she continues to see lululemon as best in class among specialty retailers, she is moving to the sidelines in anticipation of potentially less margin upside ahead, based on insights from proprietary data products. She sees measured guidance as likely, as a turbulent February likely hits lululemon just as hard as the rest of retail, which may be taken less positively by investors given the notable growth metrics and margin expansion the retailer has typically posted in recent quarters.
03/22/19
WEDB
03/22/19
DOWNGRADE
WEDB
Neutral
Lululemon downgraded to Neutral from Outperform at Wedbush

TODAY'S FREE FLY STORIES

PG

Procter & Gamble

$122.22

0.37 (0.30%)

, KO

Coca-Cola

$53.90

-0.62 (-1.14%)

08:17
09/21/19
09/21
08:17
09/21/19
08:17
Periodicals
Kellogg, Coca-Cola among staples stocks for dividends, Barron's says »

Consumer-staples stocks…

PG

Procter & Gamble

$122.22

0.37 (0.30%)

KO

Coca-Cola

$53.90

-0.62 (-1.14%)

PEP

PepsiCo

$134.49

-0.98 (-0.72%)

CL

Colgate-Palmolive

$70.97

0.01 (0.01%)

KMB

Kimberly-Clark

$135.13

0.9 (0.67%)

K

Kellogg

$63.79

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

  • 08

    Oct

  • 18

    Oct

  • 22

    Oct

  • 29

    Oct

  • 01

    Nov

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

, CMCSK

Comcast

$0.00

(0.00%)

08:09
09/21/19
09/21
08:09
09/21/19
08:09
Periodicals
Facebook, Microsoft among growth stocks for risky times, Barron's says »

Comcast (CMCSA), Delta…

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

DAL

Delta Air Lines

$58.63

-0.05 (-0.09%)

FANG

Diamondback Energy

$96.90

-0.45 (-0.46%)

EHC

Encompass Health

$64.41

-0.01 (-0.02%)

FB

Facebook

$189.88

-0.27 (-0.14%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 01

    Oct

  • 02

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

YUM

Yum! Brands

$112.31

-1.83 (-1.60%)

, MCD

McDonald's

$209.44

-1.12 (-0.53%)

08:05
09/21/19
09/21
08:05
09/21/19
08:05
Periodicals
Fast food stock could gain if consumer spending slows, Barron's says »

Despite a surge in second…

YUM

Yum! Brands

$112.31

-1.83 (-1.60%)

MCD

McDonald's

$209.44

-1.12 (-0.53%)

CMG

Chipotle

$835.17

3.67 (0.44%)

CBRL

Cracker Barrel

$166.12

-0.23 (-0.14%)

WEN

Wendy's

$20.77

0.22 (1.07%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 10

    Oct

  • 22

    Oct

  • 12

    Nov

  • 13

    Nov

SFTBF

SoftBank

$0.00

(0.00%)

, SFTBY

SoftBank

$0.00

(0.00%)

08:00
09/21/19
09/21
08:00
09/21/19
08:00
Periodicals
Softbank stock still attractive, Barron's says »

Investors seem convinced…

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REAL

RealReal

$17.00

0.21 (1.25%)

07:57
09/21/19
09/21
07:57
09/21/19
07:57
Periodicals
RealReal among year's more under-the-radar IPOs, Barron's says »

The RealReal is one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$64.28

0.65 (1.02%)

, WAB

Wabtec

$74.01

0.26 (0.35%)

07:48
09/21/19
09/21
07:48
09/21/19
07:48
Periodicals
Opioid crisis could hurt investors, Barron's says »

Opioid lawsuits have…

CVS

CVS Health

$64.28

0.65 (1.02%)

WAB

Wabtec

$74.01

0.26 (0.35%)

ABC

AmerisourceBergen

$85.13

0.475 (0.56%)

CAH

Cardinal Health

$47.89

-0.14 (-0.29%)

MCK

McKesson

$146.83

1.06 (0.73%)

MYL

Mylan

$21.01

0.03 (0.14%)

AMRX

Amneal Pharmaceuticals

$3.34

0.21 (6.71%)

ABT

Abbott

$83.56

0.35 (0.42%)

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

ENDP

Endo

$3.48

0.115 (3.42%)

TEVA

Teva

$7.44

-0.08 (-1.06%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 01

    Oct

  • 02

    Oct

  • 15

    Oct

  • 16

    Oct

  • 23

    Oct

  • 06

    Nov

  • 13

    Nov

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

07:13
09/21/19
09/21
07:13
09/21/19
07:13
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

F

Ford

$9.16

0.06 (0.66%)

GM

General Motors

$37.37

-0.41 (-1.09%)

HMC

Honda

$26.68

0.03 (0.11%)

NSANY

Nissan

$0.00

(0.00%)

TSLA

Tesla

$240.62

-5.89 (-2.39%)

TM

Toyota

$136.72

0.12 (0.09%)

VWAGY

Volkswagen

$0.00

(0.00%)

FB

Facebook

$189.88

-0.27 (-0.14%)

AGU

Agrium

$0.00

(0.00%)

ANDE

Andersons

$26.28

-0.56 (-2.09%)

ADM

Archer Daniels

$40.94

0.05 (0.12%)

BG

Bunge

$55.91

-0.26 (-0.46%)

CF

CF Industries

$49.28

-0.76 (-1.52%)

CMP

Compass Minerals

$56.29

-1.765 (-3.04%)

IPI

Intrepid Potash

$3.43

0.01 (0.29%)

POT

Potash

$0.00

(0.00%)

SYT

Syngenta

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 02

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

UPS

UPS

$120.71

1.61 (1.35%)

21:22
09/20/19
09/20
21:22
09/20/19
21:22
Conference/Events
UPS management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

DIS

Disney

$132.18

-1.14 (-0.86%)

, T

AT&T

$37.92

0.78 (2.10%)

18:17
09/20/19
09/20
18:17
09/20/19
18:17
Periodicals
Disney reaches TV carriage agreement with AT&T, Bloomberg says »

The deal includes ESPN on…

DIS

Disney

$132.18

-1.14 (-0.86%)

T

AT&T

$37.92

0.78 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

BA

Boeing

$379.33

-5.28 (-1.37%)

18:15
09/20/19
09/20
18:15
09/20/19
18:15
Periodicals
Icelandair reaches deal for Boeing to cover costs associated with 737, WSJ says »

Icelandair Group said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MCF

Contango Oil & Gas

$1.71

-0.07 (-3.93%)

17:58
09/20/19
09/20
17:58
09/20/19
17:58
Hot Stocks
Karlin Asset Management reports 11.4% passive stake in Contango Oil & Gas »

Karlin Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$142.97

1.68 (1.19%)

17:41
09/20/19
09/20
17:41
09/20/19
17:41
Hot Stocks
SPDR Gold Shares holdings rise to 894.15MT from 883.60MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXRT

Vaxart

$0.58

-0.0307 (-5.03%)

17:37
09/20/19
09/20
17:37
09/20/19
17:37
Syndicate
Vaxart files to sell 15.6M shares of common stock »

H.C. Wainwright acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

17:34
09/20/19
09/20
17:34
09/20/19
17:34
Periodicals
Apple given tariff exclusion on certain Mac Pro parts, Bloomberg says »

Apple has received U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

$39.05

-0.5 (-1.26%)

, CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

17:31
09/20/19
09/20
17:31
09/20/19
17:31
Hot Stocks
II-VI to enter S&P 400; Callon Petroleum, PriceSmart to enter S&P SmallCap600 »

S&P SmallCap 600…

IIVI

II-VI

$39.05

-0.5 (-1.26%)

CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

PSMT

PriceSmart

$60.29

-0.39 (-0.64%)

FNSR

Finisar

$24.31

1.25 (5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

  • 30

    Oct

NVR

NVR

$3,632.55

-30.45 (-0.83%)

, JEF

Jefferies Financial Group

$19.47

-0.19 (-0.97%)

17:26
09/20/19
09/20
17:26
09/20/19
17:26
Hot Stocks
NVR to replace Jefferies Financial Group in the S&P 500 at open on September 26 »

NVR (NVR) will replace…

NVR

NVR

$3,632.55

-30.45 (-0.83%)

JEF

Jefferies Financial Group

$19.47

-0.19 (-0.97%)

SPB

Spectrum Brands

$49.66

-1.395 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

NOC

Northrop Grumman

$368.25

-7.45 (-1.98%)

17:24
09/20/19
09/20
17:24
09/20/19
17:24
Hot Stocks
Northrop Grumman subsidiary awarded $1.12B Missile Defense Agency contract »

Orbital Sciences, or OSC,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSMT

PriceSmart

$60.29

-0.39 (-0.64%)

, FNSR

Finisar

$24.31

1.25 (5.42%)

17:23
09/20/19
09/20
17:23
09/20/19
17:23
Hot Stocks
Breaking Hot Stocks news story on PriceSmart, Finisar »

PriceSmart to replace…

PSMT

PriceSmart

$60.29

-0.39 (-0.64%)

FNSR

Finisar

$24.31

1.25 (5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

IIVI

II-VI

$39.05

-0.5 (-1.26%)

, CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

17:22
09/20/19
09/20
17:22
09/20/19
17:22
Hot Stocks
Breaking Hot Stocks news story on II-VI, Callon Petroleum »

II-VI to replace Callon…

IIVI

II-VI

$39.05

-0.5 (-1.26%)

CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

NVR

NVR

$3,632.55

-30.45 (-0.83%)

17:20
09/20/19
09/20
17:20
09/20/19
17:20
Hot Stocks
Breaking Hot Stocks news story on NVR »

NVR to replace Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$0.00

(0.00%)

17:12
09/20/19
09/20
17:12
09/20/19
17:12
Hot Stocks
Norsk Hydro discloses federal court in Brazil lifts embargo on Alunortes »

The Federal Court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RESN

Resonant

$3.05

0.02 (0.66%)

17:03
09/20/19
09/20
17:03
09/20/19
17:03
Conference/Events
Resonant participates in a conference call with Loop Capital »

Semiconductor Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 12

    Nov

NINE

Nine Energy Services

$6.73

-0.33 (-4.67%)

17:02
09/20/19
09/20
17:02
09/20/19
17:02
Syndicate
Breaking Syndicate news story on Nine Energy Services »

Nine Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATOM

Atomera

$3.70

0.17 (4.82%)

17:00
09/20/19
09/20
17:00
09/20/19
17:00
Conference/Events
Atomera participates in a conference call with Loop Capital »

Semiconductor Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPWR

Monolithic Power

$154.21

-2 (-1.28%)

16:50
09/20/19
09/20
16:50
09/20/19
16:50
Conference/Events
Monolithic Power participates in a conference call with Loop Capital »

Semiconductor Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.